{"id":"dalteparin-injection","safety":{"commonSideEffects":[{"rate":"1-3%","effect":"Bleeding"},{"rate":"<1%","effect":"Thrombocytopenia"},{"rate":"5-10%","effect":"Injection site hematoma"},{"rate":"5-15%","effect":"Injection site pain"},{"rate":"1-3%","effect":"Elevated liver enzymes"},{"rate":null,"effect":"Osteoporosis (with long-term use)"}]},"_chembl":{"chemblId":"CHEMBL1201460","moleculeType":"Oligosaccharide"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Dalteparin binds to and potentiates antithrombin III, a natural anticoagulant, leading to inactivation of factor Xa (more potently) and factor IIa (thrombin) in the coagulation cascade. This prevents thrombus formation and propagation. Low-molecular-weight heparins like dalteparin have more predictable pharmacokinetics and longer half-lives than unfractionated heparin, allowing for subcutaneous dosing.","oneSentence":"Dalteparin is a low-molecular-weight heparin that inhibits blood coagulation by enhancing the activity of antithrombin III against clotting factors Xa and IIa.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:44:05.575Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prophylaxis of deep vein thrombosis (DVT) in patients undergoing abdominal surgery or hip replacement surgery"},{"name":"Treatment of acute deep vein thrombosis and pulmonary embolism"},{"name":"Prophylaxis of ischemic complications in patients with unstable angina and non-Q-wave myocardial infarction"},{"name":"Extended prophylaxis of venous thromboembolism in patients with cancer"}]},"trialDetails":[{"nctId":"NCT07461545","phase":"NA","title":"Efficacy of Apixaban in the Treatment of Portal Vein Thrombosis Occurring More Than One Year After LS","status":"RECRUITING","sponsor":"Northern Jiangsu People's Hospital","startDate":"2026-02-04","conditions":"Cirrhosis, Splenectomy, Venous Thrombosis","enrollment":40},{"nctId":"NCT07312851","phase":"PHASE1","title":"A Study to Investigate Andexanet Dosing and the Interaction Between Andexanet and Subsequent Enoxaparin in Healthy Participants","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2026-01-19","conditions":"Healthy Participants","enrollment":186},{"nctId":"NCT05498428","phase":"PHASE2","title":"A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer","status":"RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2022-11-11","conditions":"Carcinoma, Non-small-Cell Lung","enrollment":520},{"nctId":"NCT07388420","phase":"NA","title":"Adding Evolocumab to Conventional Lipid-lowering Therapy for Hypertriglyceridemia Induced Acute Pancreatitis","status":"RECRUITING","sponsor":"General Hospital of Shenyang Military Region","startDate":"2026-01-02","conditions":"Hypertriglyceridemia Induced Acute Pancreatitis","enrollment":40},{"nctId":"NCT05569681","phase":"NA","title":"Two Different Regimens of Bemiparin as a Thromboprophylaxis in Morbidly Obese Surgical Patients","status":"RECRUITING","sponsor":"Hawler Medical University","startDate":"2023-01-07","conditions":"Morbid Obesity","enrollment":2400},{"nctId":"NCT06370273","phase":"PHASE3","title":"Thromboprophylaxis in Lower Limb Immobilisation","status":"RECRUITING","sponsor":"Queen Mary University of London","startDate":"2024-11-12","conditions":"Thrombosis, Injury Leg","enrollment":10044},{"nctId":"NCT06937372","phase":"NA","title":"Delivery and Implementation of a Randomised Crossover Trial on Thrombosis","status":"NOT_YET_RECRUITING","sponsor":"Queen Mary University of London","startDate":"2026-08-01","conditions":"Hip Fractures, Venous Thromboembolism (VTE)","enrollment":21194},{"nctId":"NCT07270263","phase":"NA","title":"Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies","status":"RECRUITING","sponsor":"Medical University of Gdansk","startDate":"2024-11-22","conditions":"Lymphoma, Leukemia, Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma","enrollment":100},{"nctId":"NCT02855047","phase":"","title":"The Prognostic Value of PGF and sFlt1 Variations Induced by the First Low-molecular-weight-heparin Injections in Women With Obstetrical Antiphospholipids Antibody Syndrome Starting a New Pregnancy and Following Treatment in Accordance With International Recommendations","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2005-07","conditions":"Antiphospholipid Syndrome","enrollment":513},{"nctId":"NCT01588171","phase":"NA","title":"Comparison of 2 Low Molecular Weight Heparin as a Thromboprophylaxis Postpartum","status":"COMPLETED","sponsor":"Hawler Medical University","startDate":"2012-05","conditions":"Venous Thromboembolic Diseases","enrollment":7020},{"nctId":"NCT07213713","phase":"","title":"Evaluation of Anti-Xa Activity in Patients With Severe Obesity After Subcutaneous Injection of Enoxaparin for Antithrombotic Prophylaxis at Two Different Sites.","status":"NOT_YET_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2025-10-01","conditions":"Venous Thromboembolism, Obese Patients","enrollment":80},{"nctId":"NCT07195955","phase":"NA","title":"Cold Spray for Pain and Ecchymosis After Anticoagulant Prophylaxis in Orthopedic Surgery","status":"COMPLETED","sponsor":"Kocaeli University","startDate":"2024-02-01","conditions":"Nursing Care, Cold Application, Pain","enrollment":101},{"nctId":"NCT03244020","phase":"PHASE4","title":"LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology","status":"ENROLLING_BY_INVITATION","sponsor":"Massachusetts General Hospital","startDate":"2018-02-16","conditions":"Sarcoma, Soft Tissue Sarcoma, Bone Sarcoma","enrollment":2868},{"nctId":"NCT06180889","phase":"PHASE2","title":"Factor XI inhibiTion for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty","status":"ACTIVE_NOT_RECRUITING","sponsor":"Suzhou Alphamab Co., Ltd.","startDate":"2023-12-20","conditions":"Knee Arthroplasty, Total","enrollment":241},{"nctId":"NCT07168005","phase":"NA","title":"Informative Video Before LMWH Postpartum - Randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"Wolfson Medical Center","startDate":"2025-10-15","conditions":"Venous Thromboembolism (VTE), Postpartum Care, Anxiety","enrollment":160},{"nctId":"NCT06776159","phase":"NA","title":"The Effect of Standardizing Procedures for SC Injections of LMWH on Patients With CVD","status":"RECRUITING","sponsor":"The Hong Kong Polytechnic University","startDate":"2025-06-24","conditions":"CVD - Cardiovascular Disease, Bruise, Pain","enrollment":180},{"nctId":"NCT04762992","phase":"PHASE3","title":"LMWH for Treatment of Early Fetal Growth Restriction (HepaGrowth)","status":"ENROLLING_BY_INVITATION","sponsor":"Centro Hospitalar de Lisboa Central","startDate":"2022-07-18","conditions":"Fetal Growth Retardation, Prematurity, Pre-Eclampsia","enrollment":12},{"nctId":"NCT06991530","phase":"","title":"Effect of Low Molecular Weight Heparin in Freeze-thaw Embryo Transfer Cycles in Women With Recurrent Implantation Failure","status":"COMPLETED","sponsor":"The Second Hospital of Shandong University","startDate":"2021-01-01","conditions":"Low Molecular Weight Heparin, Recurrent Implantation Failure, FET","enrollment":392},{"nctId":"NCT07116239","phase":"NA","title":"Edoxaban Steady-State PK/PD in Adults With Nephrotic Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2025-09","conditions":"Nephrotic Syndrome, Hypoalbuminemia","enrollment":60},{"nctId":"NCT07087366","phase":"NA","title":"Enhanced Recovery After Surgery(ERAS) Following Gynaecological Oncology Surgery in a Tertiary Level Hospital","status":"RECRUITING","sponsor":"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh","startDate":"2025-06-01","conditions":"ERAS, Cancer","enrollment":130},{"nctId":"NCT06712004","phase":"PHASE2","title":"A Dose-Response Controlled Trial of Bevifibatide for Acute Ischemic Stroke","status":"RECRUITING","sponsor":"Zhujiang Hospital","startDate":"2025-02-10","conditions":"Ischemic Stroke, Acute, Ischemic Stroke, Cerebral Infarction","enrollment":40},{"nctId":"NCT03045406","phase":"PHASE3","title":"Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer","status":"COMPLETED","sponsor":"Fadoi Foundation, Italy","startDate":"2017-04-13","conditions":"Venous Thromboembolism","enrollment":1170},{"nctId":"NCT05634057","phase":"NA","title":"Efficacy of Anisodamine Hydrobromide Combined With Low-molecular-weight Heparin in the Treatment of Patients With Sepsis","status":"RECRUITING","sponsor":"Chen Ying","startDate":"2024-01-25","conditions":"Sepsis","enrollment":782},{"nctId":"NCT04645550","phase":"PHASE4","title":"Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy（ESAWAAPT）","status":"COMPLETED","sponsor":"Northern Jiangsu People's Hospital","startDate":"2020-11-22","conditions":"Cirrhosis, Splenectomy; Status, Venous Thrombosis","enrollment":120},{"nctId":"NCT05681338","phase":"NA","title":"Effect of the Coughing Technique During Subcutaneous Heparin Injection","status":"COMPLETED","sponsor":"Uludag University","startDate":"2022-03-17","conditions":"Thyroidectomy, Colon Surgery, Cholecystectomy","enrollment":60},{"nctId":"NCT00277394","phase":"PHASE4","title":"Innohep® in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein Thrombosis","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2005-12","conditions":"Deep Vein Thrombosis","enrollment":541},{"nctId":"NCT06494878","phase":"PHASE3","title":"The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity","status":"NOT_YET_RECRUITING","sponsor":"University of Calgary","startDate":"2025-04","conditions":"Venous Thromboembolism, Postpartum Period, Aspirin","enrollment":8805},{"nctId":"NCT05284552","phase":"PHASE2","title":"Tinzaparin And Biomarkers After Neoadjuvant Treatment of Ovarian Cancer","status":"RECRUITING","sponsor":"University Hospital, Linkoeping","startDate":"2022-07-12","conditions":"Epithelial Ovarian Cancer","enrollment":40},{"nctId":"NCT01130025","phase":"PHASE3","title":"Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2010-08","conditions":"Venous Thromboembolism","enrollment":900},{"nctId":"NCT06829407","phase":"NA","title":"Effect of Different Subcutaneous Injection Methods on Pain and Satisfaction","status":"COMPLETED","sponsor":"Trakya University","startDate":"2024-08-20","conditions":"Pain, Acute, Injection Site","enrollment":112},{"nctId":"NCT04507178","phase":"PHASE2","title":"Improving Outcome in Subarachnoid Hemorrhage wIth Nadroparine","status":"RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2022-02-02","conditions":"Aneurysmal Subarachnoid Hemorrhage, Delayed Cerebral Ischemia","enrollment":100},{"nctId":"NCT04710732","phase":"PHASE4","title":"Individual Dose Adjustment of Low-molecular-weight-heparin by Thromodynamics Test.","status":"TERMINATED","sponsor":"Pirogov Russian National Research Medical University","startDate":"2021-03-01","conditions":"Venous Thromboembolism","enrollment":9},{"nctId":"NCT04505774","phase":"PHASE4","title":"Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE","status":"COMPLETED","sponsor":"Matthew Neal MD","startDate":"2020-09-04","conditions":"Covid19","enrollment":3591},{"nctId":"NCT06693362","phase":"PHASE1","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Uterine Blood Mesenchymal Stem Cells Injection for the Treatment of Severe Pneumonia Caused by Viruses","status":"RECRUITING","sponsor":"Ruijin Hospital","startDate":"2025-01-20","conditions":"Severe Viral Pneumonia(Not Include COVID-19)","enrollment":60},{"nctId":"NCT04427098","phase":"PHASE2","title":"Enoxaparin in COVID-19 Moderate to Severe Hospitalized Patients","status":"COMPLETED","sponsor":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","startDate":"2020-05-22","conditions":"COVID-19","enrollment":301},{"nctId":"NCT04088292","phase":"PHASE3","title":"Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism","status":"ACTIVE_NOT_RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2019-06-06","conditions":"Pulmonary Embolism","enrollment":210},{"nctId":"NCT06442267","phase":"PHASE4","title":"Comparing Anticoagulation Strategies Using UFH, Argatroban and LMWH for ECMO Support","status":"RECRUITING","sponsor":"Medical University of Vienna","startDate":"2024-07-30","conditions":"Respiratory Insufficiency, Circulatory Failure, Thromboembolism","enrollment":90},{"nctId":"NCT03559114","phase":"PHASE3","title":"PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST)","status":"RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2018-07-19","conditions":"Traumatic Brain Injury","enrollment":1100},{"nctId":"NCT01630148","phase":"NA","title":"Bemiparin as a Thromboprophylaxis After Gynaecological Surgeries","status":"COMPLETED","sponsor":"Hawler Medical University","startDate":"2012-07","conditions":"Deep Vein Thrombosis (DVT), Pulmonary Embolism","enrollment":774},{"nctId":"NCT06563648","phase":"NA","title":"The Effect of Local Cold Application and ShotBlocker Use in Subcutaneous Injection on Injection Pain and Patient Satisfaction","status":"COMPLETED","sponsor":"Bornova No. 25 Mevlana Family Health Center","startDate":"2022-01-01","conditions":"Pain, Satisfaction, Patient","enrollment":208},{"nctId":"NCT06259149","phase":"","title":"A Study of Initiation Timing of VTE Prevention After Colorectal Cancer Surgery","status":"RECRUITING","sponsor":"RenJi Hospital","startDate":"2024-02-01","conditions":"Colorectal Cancer","enrollment":914},{"nctId":"NCT06531525","phase":"PHASE2","title":"Effect of Low Molecular Heparin on Pregnancy Outcome With Protein S Deficiency","status":"NOT_YET_RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2024-08-01","conditions":"Pregnancy Related, Protein S Deficiency","enrollment":48},{"nctId":"NCT06513481","phase":"","title":"A Study of Enhancing Drug Prophylaxis of Venous Thromboembolism in Chinese Colorectal Cancer Surgery","status":"NOT_YET_RECRUITING","sponsor":"RenJi Hospital","startDate":"2024-07-16","conditions":"Colorectal Cancer","enrollment":914},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT04164693","phase":"NA","title":"Efficacy and Safety of Short-term Postoperative Anticoagulant Therapy to Prevente Thrombosis in Arterovenous Fistula","status":"COMPLETED","sponsor":"First Affiliated Hospital of Chongqing Medical University","startDate":"2019-01-01","conditions":"Thrombosis","enrollment":287},{"nctId":"NCT06443905","phase":"","title":"Xueshuantong Injection (Lyophilized) in the Prevention of Venous Thromboembolism (VTE) in Hospitalized Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"China-Japan Friendship Hospital","startDate":"2023-08-01","conditions":"Venous Thromboembolism (VTE), Thromboembolism","enrollment":21600},{"nctId":"NCT02984384","phase":"PHASE3","title":"PREVENTion of Clot in Orthopaedic Trauma","status":"COMPLETED","sponsor":"Major Extremity Trauma Research Consortium","startDate":"2017-04-24","conditions":"Blood Clot, Trauma","enrollment":12424},{"nctId":"NCT05081375","phase":"PHASE4","title":"Pre-operative Enoxaparin in the Surgical Management of Multi-trauma Patients Undergoing Orthopedic Surgical Procedures","status":"TERMINATED","sponsor":"Valleywise Health","startDate":"2019-12-16","conditions":"Venous Thrombosis Deep (Limbs), Surgical Blood Loss","enrollment":6},{"nctId":"NCT06153394","phase":"PHASE3","title":"Prolonged Hypercoagulability Following Major Liver Resection for Malignancy","status":"NOT_YET_RECRUITING","sponsor":"Western University, Canada","startDate":"2024-06-01","conditions":"Hepatic Disease, Surgery-Complications, Hypercoagulability","enrollment":50},{"nctId":"NCT00942968","phase":"PHASE4","title":"Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer","status":"COMPLETED","sponsor":"Pfizer","startDate":"2009-06","conditions":"Cancer","enrollment":338},{"nctId":"NCT06367036","phase":"NA","title":"Effect of Hypericum Perforatum Oil on Ecchymosis and Pain","status":"COMPLETED","sponsor":"Uskudar University","startDate":"2022-01-02","conditions":"Pain, Ecchymosis","enrollment":160},{"nctId":"NCT02342444","phase":"PHASE4","title":"Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)","status":"RECRUITING","sponsor":"Oregon Health and Science University","startDate":"2014-02","conditions":"Trauma, Surgery, Deep Vein Thrombosis (DVT)","enrollment":606},{"nctId":"NCT06038682","phase":"","title":"Monitoring Anticoagulation in Patients on ECMO for Severe Lung Failure","status":"COMPLETED","sponsor":"University Hospital Ostrava","startDate":"2020-04-01","conditions":"ARDS, COVID-19","enrollment":100},{"nctId":"NCT06133803","phase":"PHASE4","title":"Lovenox With Aspirin in Thawed Blastocyst Transfer","status":"UNKNOWN","sponsor":"Fertility Center of Las Vegas","startDate":"2024-01-26","conditions":"Infertility, Female","enrollment":130},{"nctId":"NCT05833646","phase":"NA","title":"Comparison of the Effects of ShotBlocker, Virtual Reality Glasses and Cold Application in Subcutaneous Heparin Injection","status":"COMPLETED","sponsor":"Ankara Yildirim Beyazıt University","startDate":"2023-03-01","conditions":"Subcutaneous Injection","enrollment":150},{"nctId":"NCT03297359","phase":"PHASE2","title":"WAVe Study - Weight Adjusted Dalteparin for Patients Over 90 kg With Acute Cancer Associated Venous Thromboembolism","status":"TERMINATED","sponsor":"Ottawa Hospital Research Institute","startDate":"2018-03-21","conditions":"Cancer, Venous Thromboembolism, Obesity","enrollment":92},{"nctId":"NCT05304455","phase":"NA","title":"Apixaban Prevents Portal Vein Thrombosis After Laparoscopic Splenectomy and Azygoportal Disconnection","status":"COMPLETED","sponsor":"Northern Jiangsu People's Hospital","startDate":"2022-04-01","conditions":"Cirrhosis, Splenectomy, Venous Thrombosis","enrollment":40},{"nctId":"NCT06166914","phase":"NA","title":"Efficacy of 5-fluorouracil and Low Molecular Weight Heparin in High-risk Pediatric Retinal Detachment","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2021-10-21","conditions":"Retinal Detachment, Proliferative Vitreoretinopathy","enrollment":42},{"nctId":"NCT04918524","phase":"","title":"The Clinical Features and Pregnancy Outcomes of CTD Patients","status":"RECRUITING","sponsor":"Qilu Hospital of Shandong University","startDate":"2018-09-11","conditions":"Connective Tissue Diseases, Pregnancy Related","enrollment":126},{"nctId":"NCT04976465","phase":"PHASE1","title":"Treatment and Clinical Outcomes Among SLE Patients in Pregnancy","status":"RECRUITING","sponsor":"Qilu Hospital of Shandong University","startDate":"2018-01-01","conditions":"Systemic Lupus Erythematosus, Pregnancy Related","enrollment":200},{"nctId":"NCT06076434","phase":"NA","title":"Low-Molecular-Weight Heparin Injection in Stroke Patients","status":"COMPLETED","sponsor":"Kastamonu University","startDate":"2022-11-01","conditions":"Stroke","enrollment":50},{"nctId":"NCT06023485","phase":"NA","title":"The Effect of Stress Ball Use on Procedural Pain Caused by Subcutaneous Injection in Orthopedic Patients","status":"UNKNOWN","sponsor":"Kırklareli University","startDate":"2023-03-01","conditions":"Misadventure During Injection / Vaccination","enrollment":134},{"nctId":"NCT06049758","phase":"NA","title":"D2 Versus D3 Dissection in Laparoscopic Right Hemicolectomy","status":"NOT_YET_RECRUITING","sponsor":"General Committee of Teaching Hospitals and Institutes, Egypt","startDate":"2024-01-02","conditions":"Blood Loss, Intensive Care, Anastomotic Leakage","enrollment":80},{"nctId":"NCT01583218","phase":"PHASE3","title":"Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)","status":"COMPLETED","sponsor":"Portola Pharmaceuticals","startDate":"2012-03","conditions":"Venous Thromboembolism (VTE)","enrollment":7513},{"nctId":"NCT04646655","phase":"PHASE3","title":"Enoxaparin at Prophylactic or Therapeutic Doses in COVID-19","status":"COMPLETED","sponsor":"ASST Fatebenefratelli Sacco","startDate":"2020-07-27","conditions":"Covid19, Thrombosis","enrollment":142},{"nctId":"NCT02607319","phase":"PHASE4","title":"Low Molecular Weight Heparin to Improve Pregnancy Outcome in Patients With Recurrent Implantation Failure","status":"COMPLETED","sponsor":"American University of Beirut Medical Center","startDate":"2015-11","conditions":"Sterility","enrollment":165},{"nctId":"NCT04305106","phase":"PHASE3","title":"Bevacizumab in Patients With Severe Covid-19","status":"UNKNOWN","sponsor":"Qilu Hospital of Shandong University","startDate":"2023-01-12","conditions":"COVID-19 Pneumonia","enrollment":588},{"nctId":"NCT03664180","phase":"PHASE4","title":"Comparison of Anticoagulation Prolongation vs. no Anticoagulation in STEMI Patients After Primary PCI","status":"COMPLETED","sponsor":"Beijing Anzhen Hospital","startDate":"2019-01-11","conditions":"STEMI - ST Elevation Myocardial Infarction","enrollment":2989},{"nctId":"NCT02923115","phase":"PHASE1, PHASE2","title":"Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2016-06-23","conditions":"Pulmonary Embolism, Thrombotic Disease","enrollment":134},{"nctId":"NCT05382481","phase":"NA","title":"Anti Xa Monitoring Low Molecular Weight Heparin on Prevention of Venous Thromboembolism","status":"UNKNOWN","sponsor":"Xuanwu Hospital, Beijing","startDate":"2022-05-16","conditions":"Venous Thromboembolism","enrollment":858},{"nctId":"NCT05771285","phase":"NA","title":"Cold Application on the Subcutaneous Injection","status":"COMPLETED","sponsor":"Yuksek Ihtisas University","startDate":"2017-01","conditions":"Injection Site Bruising, Bruising, Pain","enrollment":78},{"nctId":"NCT03809481","phase":"PHASE3","title":"Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study Safety and Efficacy of Danaparoid vs Argatroban","status":"TERMINATED","sponsor":"Aspen Global Incorporated","startDate":"2019-05-16","conditions":"Heparin-induced Thrombocytopenia","enrollment":7},{"nctId":"NCT05621915","phase":"","title":"Nadroparin Pharmacokinetics in Different Stages of COVID-19","status":"COMPLETED","sponsor":"Medical University of Lublin","startDate":"2021-02-01","conditions":"Thrombosis, Nadroparin, COVID-19","enrollment":43},{"nctId":"NCT04400799","phase":"PHASE3","title":"Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19","status":"TERMINATED","sponsor":"University of Zurich","startDate":"2020-06-15","conditions":"COVID-19, Pulmonary Embolism, Deep Vein Thrombosis","enrollment":475},{"nctId":"NCT04492254","phase":"PHASE3","title":"Early Prophylactic Low-molecular-weight Heparin (LMWH) in Symptomatic COVID-19 Positive Patients","status":"TERMINATED","sponsor":"Thrombosis Research Institute","startDate":"2020-10-27","conditions":"COVID-19","enrollment":219},{"nctId":"NCT05302947","phase":"","title":"COVID-19 Study at the Russian Clinical and Research Center of Gerontology of the Pirogov RNRMU","status":"COMPLETED","sponsor":"Pirogov Russian National Research Medical University","startDate":"2020-02-01","conditions":"COVID-19, Mild to Moderate","enrollment":154},{"nctId":"NCT04110444","phase":"","title":"Sildenafil Citrate Added to Low Molecular Weight Heparin and Low Dose Aspirin in High-risk Pregnancy","status":"WITHDRAWN","sponsor":"Fayoum University Hospital","startDate":"2017-01","conditions":"High Risk Pregnancy","enrollment":""},{"nctId":"NCT04394182","phase":"NA","title":"Ultra Low Doses of Therapy With Radiation Applicated to COVID-19","status":"SUSPENDED","sponsor":"Fundacion GenesisCare","startDate":"2020-04-21","conditions":"Pneumonia, Viral, Cytokine Storm","enrollment":15},{"nctId":"NCT05265676","phase":"PHASE1","title":"Bioequivalence Study of a Generic Enoxaparin Sodium to Clexane® After Single Subcutaneous Dose in Healthy Human Subjects","status":"COMPLETED","sponsor":"Venus Remedies Limited","startDate":"2021-02-26","conditions":"Healthy","enrollment":24},{"nctId":"NCT03862755","phase":"PHASE4","title":"Chemoprophylaxis Plus Early Ambulation","status":"COMPLETED","sponsor":"Shen Lei","startDate":"2017-08-08","conditions":"Pulmonary Embolism, Thoracic Surgery","enrollment":581},{"nctId":"NCT04727437","phase":"PHASE3","title":"STOPping Anticoagulation for Isolated or Incidental Subsegmental Pulmonary Embolism","status":"UNKNOWN","sponsor":"University of Birmingham","startDate":"2021-04-08","conditions":"Subsegmental Pulmonary Embolism Nos","enrollment":1466},{"nctId":"NCT04380818","phase":"NA","title":"Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19","status":"UNKNOWN","sponsor":"Grupo de Investigación Clínica en Oncología Radioterapia","startDate":"2020-06-05","conditions":"Pneumonia, Viral","enrollment":106},{"nctId":"NCT02444572","phase":"PHASE4","title":"Comparison of Thromboembolic Events in Patients Undergoing Thromboprophylactic Treatment With ENOXA® vs Lovenox®","status":"COMPLETED","sponsor":"Les Laboratoires des Médicaments Stériles","startDate":"2015-10","conditions":"Gastrointestinal Neoplasms, Thromboembolic Event","enrollment":168},{"nctId":"NCT04274803","phase":"PHASE4","title":"Dose Intralipid Infusion Reduces Pregnancy Complications Caused by Antiphospholipid Antibody Syndrome?","status":"WITHDRAWN","sponsor":"Tanta University","startDate":"2020-04-01","conditions":"Antiphospholipid Syndrome in Pregnancy","enrollment":""},{"nctId":"NCT01455831","phase":"PHASE3","title":"Extended Peri-operative Tinzaparin to Improve Disease-free Survival in Patients With Resectable Colorectal Cancer","status":"COMPLETED","sponsor":"Ottawa Hospital Research Institute","startDate":"2011-09","conditions":"Adenocarcinoma of the Colon","enrollment":616},{"nctId":"NCT04778917","phase":"PHASE4","title":"Observation and Treatment of Pulmonary Microthrombosis in Childhood Pneumonia With Elevated D-dimer","status":"COMPLETED","sponsor":"Capital Institute of Pediatrics, China","startDate":"2014-12","conditions":"Pneumonia","enrollment":124},{"nctId":"NCT04584580","phase":"PHASE4","title":"D-dimer Adjusted Versus Therapeutic Dose Low-molecular-weight Heparin in Patients With COVID-19 Pneumonia","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2020-08-01","conditions":"Coronavirus Disease (COVID)19","enrollment":50},{"nctId":"NCT00633061","phase":"PHASE2","title":"Identification and Treatment of Clinically Silent Catheter-Related Deep Vein Thrombosis in Children With Cancer","status":"TERMINATED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2008-06","conditions":"Childhood Cancer, Central Venous Catheters, Deep Vein Thrombosis","enrollment":136},{"nctId":"NCT04445935","phase":"PHASE4","title":"Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO Trial","status":"UNKNOWN","sponsor":"Hamad Medical Corporation","startDate":"2020-06-28","conditions":"Anticoagulation in COVID-19 ARDS","enrollment":100},{"nctId":"NCT04402762","phase":"PHASE1, PHASE2","title":"Pharmacodynamic Equivalence of Ovine Enoxaparin to Lovenox®","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2019-12-20","conditions":"Enoxaparin","enrollment":20},{"nctId":"NCT03276143","phase":"PHASE2","title":"FactOr XIa inhibiTion for the pRevention of venOus Thromboembolism in Patients Undergoing Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Bayer","startDate":"2017-09-21","conditions":"Knee Arthroplasty, Total","enrollment":813},{"nctId":"NCT00432796","phase":"PHASE3","title":"PERIOP 2 - A Safety and Effectiveness of LMWH vs Placebo Bridging Therapy for Patients on Long Term Warfarin Requiring Temporary Interruption of Warfarin.","status":"UNKNOWN","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2006-12","conditions":"Stroke","enrollment":1473},{"nctId":"NCT04235569","phase":"PHASE4","title":"Warfarin Initiation in Mechanical Mitral Valve Replacement Patients","status":"COMPLETED","sponsor":"Sarah Sabry Hashem","startDate":"2018-03-01","conditions":"Mitral Valve Disease","enrollment":50},{"nctId":"NCT04169269","phase":"PHASE4","title":"Deep Vein Thrombosis Prophylaxis Adherence: Enoxaparin vs Rivaroxaban","status":"UNKNOWN","sponsor":"Florida Orthopaedic Institute","startDate":"2020-01-13","conditions":"Deep Vein Thrombosis, Venous Thromboembolism","enrollment":128},{"nctId":"NCT03099031","phase":"","title":"Non Interventional Study of the Validation of the Ottawa Score in Cancer Patients With Venous Thromboembolism (VTE)","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2015-05","conditions":"Venous Thromboembolism","enrollment":420},{"nctId":"NCT02589145","phase":"PHASE1, PHASE2","title":"Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2016-06-22","conditions":"Lymphoma","enrollment":8},{"nctId":"NCT02396732","phase":"PHASE4","title":"Aspirin and Enoxaparin for VTE in Trauma","status":"TERMINATED","sponsor":"University of Miami","startDate":"2016-02","conditions":"Venous Thromboembolism, Thromboprophylaxis, Trauma","enrollment":31},{"nctId":"NCT02935530","phase":"PHASE3","title":"Thromboprophylaxis After Surgery for Gynecologic Malignancy in China","status":"COMPLETED","sponsor":"Huazhong University of Science and Technology","startDate":"2016-01","conditions":"Gynecologic Neoplasms, Venous Thromboembolism, Low Molecular Weight Heparin","enrollment":315},{"nctId":"NCT00952380","phase":"PHASE2","title":"Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients","status":"COMPLETED","sponsor":"Pfizer","startDate":"2009-08","conditions":"Venous Thromboembolism","enrollment":38},{"nctId":"NCT02247414","phase":"PHASE4","title":"Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection","status":"COMPLETED","sponsor":"Yangzhou University","startDate":"2014-09","conditions":"Cirrhosis, Hypertension, Status;Splenectomy","enrollment":124}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"RENAL FAILURE"}],"_approvalHistory":[],"publicationCount":5,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Fragmin","Fragmin® is a registered trademark of Pfizer Health AB","brand name is fragmin","Active comparator","DAL"],"phase":"marketed","status":"active","brandName":"dalteparin injection","genericName":"dalteparin injection","companyName":"University of Rochester","companyId":"university-of-rochester","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Dalteparin is a low-molecular-weight heparin that inhibits blood coagulation by enhancing the activity of antithrombin III against clotting factors Xa and IIa. Used for Prophylaxis of deep vein thrombosis (DVT) in patients undergoing abdominal surgery or hip replacement surgery, Treatment of acute deep vein thrombosis and pulmonary embolism, Prophylaxis of ischemic complications in patients with unstable angina and non-Q-wave myocardial infarction.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}